Intrinsic Value

BioXcel Therapeutics, Inc. (BTAI)


+1.16 (+5.97%)

Enterprise Value -
Net Debt -99.89
Equity Value -
Shares Outstanding 28.02
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt